Abstract
Objective: To verify the effects on the lipid profile of a product of fermented milk (Gaio®) in patients with mild to moderate primary hypercholesterolemia.
Design: The study was prospective, randomized, double-blinded and placebo controlled, with a crossover design. Subjects: Thirty-two patients (21 women and 11 men) with ages ranging between 36 and 65 years old were included in the study. All of them were on a controlled diet for at least 8 weeks.
Intervention: Patients began, after clinical and laboratory analysis, in a randomized and double-blind manner to take 200 g daily of Gaio® or its placebo. After 8 weeks blood was collected again for lipid profile evaluation and the crossover was made. After an additional 8 weeks blood was collected for another lipid profile determination.
Results: All patients included completed the study. Comparisons were made between means of lipid profile constituents after the placebo and active product periods. These showed significant mean reduction of 5.3% (P=0.004) for total cholesterol, 6.15% (P=0.012) for LDL-cholesterol and no significant variation for HDL-cholesterol and triglycerides. The majority of patients presented no variation or had a decrease in their total cholesterol level. However, during the active product period, three patients showed an increase in cholesterol level by more than 5%.
Conclusion: The fermented milk (Gaio®) produced a small but statistically significant decrease in total and LDL-cholesterol mean. However, not all subjects seem to respond to the product, and a few subjects showed a cholesterol increment. Further investigations are necessary to clarify this aspect.
Sponsorship: Vigor Company, Brazil sponsored the study.
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bertolami, M., Faludi, A. & Batlouni, M. Evaluation of the effects of a new fermented milk product (Gaio) on primary hypercholesterolemia. Eur J Clin Nutr 53, 97–101 (1999). https://doi.org/10.1038/sj.ejcn.1600683
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.ejcn.1600683
- Springer Nature Limited
Keywords
This article is cited by
-
Effects of products designed to modulate the gut microbiota on hyperlipidaemia
European Journal of Nutrition (2019)
-
Effects of Bifidobacterium animalis subsp. lactis BB-12® on the lipid/lipoprotein profile and short chain fatty acids in healthy young adults: a randomized controlled trial
Nutrition Journal (2017)
-
Current Perspectives on Antihypertensive Probiotics
Probiotics and Antimicrobial Proteins (2017)
-
High fat diet induced atherosclerosis is accompanied with low colonic bacterial diversity and altered abundances that correlates with plaque size, plasma A-FABP and cholesterol: a pilot study of high fat diet and its intervention with Lactobacillus rhamnosus GG (LGG) or telmisartan in ApoE−/− mice
BMC Microbiology (2016)
-
The effects of probiotic bacteria on glycaemic control in overweight men and women: a randomised controlled trial
European Journal of Clinical Nutrition (2014)